泰国老年人与心房的华法林坚持及其相关因素
Autchariya Poungkaew1, Thitipong Tankumpuan2, Chontira Riangkam1
1Department of Medical Nursing, Faculty of Nursing, Mahidol University, Bangkok, Thailand.
Journal of multidisciplinary healthcare
|September 19, 2024
概括
家庭支持和坚持每日华法林剂量显著改善了心房动的老年人服用药物的坚持. 医疗保健系统应该利用家庭参与,以提高资源有限的环境中华法林治疗结果.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 卫生系统研究 卫生系统研究
背景情况:
- 老年人经常难以遵守华法林治疗指南.
- 医疗保健系统在改善老年人群的药物坚持方面面临着挑战,尤其是在资源有限的情况下.
研究的目的:
- 探索影响老年人食华法林的卫生系统因素.
- 专注于在资源有限的环境中面临的坚持挑战.
主要方法:
- 横截面预测研究设计.
- 招募了197名老年人 (≥60岁) 在华法林治疗中患有心房动.
- 在华法林诊所进行的随访.
主要成果:
- 85.8%的参与者报告了对华法林的坚持.
- 与家人生活,定期服用每日剂量,感知有针对性的INR,并获得家庭支持与增加华法林守有关.
- 感知到的药物障碍与降低药物坚持有关.
结论:
- 医疗保健系统应该促进对心房的老年人的家庭支持,以改善华法林的坚持.
- 未来的研究应侧重于整合家庭支持的干预措施,以加强华法林的坚持.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
Factors Affecting Protein-Drug Binding: Patient-Related Factors
45
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
45
Factors affecting Blood pressure
3.0K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.0K
Factors Affecting Protein-Drug Binding: Drug Interactions
115
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
115
Disorders of Hemostasis
739
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
739


